EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

After the green light: Evaluating drugs in Phase IV studies

Bikash Ranjan Meher, Archana Mishra

Indian Journal of Pharmacology · 2026-05 · 58 (3) · 189-195

DOI: 10.4103/ijp.ijp_427_25 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Indian Journal of Pharmacology, online erschienen am 01.05.2026. Verfasst von Bikash Ranjan Meher und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India. Hauptthemen laut MEDLINE: Clinical Trials, Phase IV as Topic, Drug Development. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The drug development process is lengthy and complex and Phase IV is a crucial phase within it. Phase IV studies are conducted after a drug has been approved by regulatory agencies to further evaluate its safety, efficacy, usefulness in special populations, new indications, and new formulations. There are many examples of Phase IV studies; not all Phase IV studies are postmarketing surveillance (PMS) studies, but every PMS study is an example of a Phase IV study. Phase IV studies are imperative as they evaluate the drug’s effectiveness and performance in real-world clinical practice and premarketing trials have some inherent limitations. Phase IV studies can be observational or interventional studies, depending on the objectives of such studies. A drug utilization study is a Phase IV study; similarly, a registry is also an example of a Phase IV study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials, Phase IV as TopicDrug DevelopmentHumansProduct Surveillance, Postmarketing

Stichwörter der Autor:innen

EffectivenessPost-marketing safety surveillancegeneralizabilityreal-world study

Autor:innen und Institutionen

  • Department of Pharmacology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.

Zitieren

APA

Meher, B. R., & Mishra, A. (2026). After the green light: Evaluating drugs in Phase IV studies. Indian Journal of Pharmacology, 58(3), 189-195. https://doi.org/10.4103/ijp.ijp_427_25

Vancouver

Meher BR, Mishra A. After the green light: Evaluating drugs in Phase IV studies. Indian Journal of Pharmacology. 2026;58(3):189-195. doi:10.4103/ijp.ijp_427_25

BibTeX
@article{Meher2026,
  author = {Meher, Bikash Ranjan and Mishra, Archana},
  title = {After the green light: Evaluating drugs in Phase IV studies},
  journal = {Indian Journal of Pharmacology},
  year = {2026},
  volume = {58},
  number = {3},
  pages = {189--195},
  doi = {10.4103/ijp.ijp_427_25}
}
Kostenlos starten →